ASSOCIATION OF PEDIATRIC HEMATOLOGY/ONCOLOGY NURSES
APHON CHEMO CERTIFICATION EXAM 2026/2027 QUESTIONS
WITH 100% SOLVED ANSWERS!! 2026/2027
CHEMOTHERAPY CERTIFICATION - Official Exam 2026/2027
100 80% CERTIFIED
QUESTIONS PASSING SCORE RECERTIFICATION
TABLE OF CONTENTS
Section 1 Chemotherapy Drug Classification & Mechanisms Q1-Q20
Section 2 Safe Handling & Administration of Chemotherapy Q21-Q40
Section 3 Toxicity & Side Effect Management Q41-Q60
Section 4 Patient Assessment & Education Q61-Q80
Section 5 Oncologic Emergencies & Special Considerations Q81-Q100
Instructions: Select the single best answer for each question. This exam is designed for APHON Chemotherapy Certification preparation.
Passing score: 80% (80 questions correct).
APHON CHEMO CERTIFICATION EXAM 2026/2027 QUESTIONS WITH 100% SOLVED ANSWERS!! 2026/2027 - 2026/2027 | Passing Score: 80% | Page 1 of 52
,SECTION 1 | Chemotherapy Drug Classification & Mechanisms | Q1-Q20 | APHON CHEMO CERTIFICATION EXAM 2026/2027 QUESTIONS WITH 100% SOLVED ANSWERS!!
2026/2027 2026/2027
Q1 Question 1 of 100
Q1. A 7-year-old boy with acute lymphoblastic leukemia begins induction therapy. The oncologist orders
vincristine as part of the protocol. The nurse understands that vincristine belongs to which chemotherapeutic
drug class based on its mechanism of action?
A. Alkylating agent that crosslinks DNA strands to prevent cell replication
B. Vinca alkaloid that inhibits microtubule formation and arrests mitosis in M phase
C. Antimetabolite that mimics folate and blocks thymidylate synthase
D. Anthracycline that intercalates DNA and inhibits topoisomerase II
Correct Answer: A
Rationale:
Vincristine is a vinca alkaloid that binds to tubulin, preventing microtubule polymerization and arresting the cell cycle in M
phase. Alkylating agents crosslink DNA, antimetabolites mimic natural substrates, and anthracyclines intercalate DNA, but
none of these describe vincristine's mechanism.
Q2 Question 2 of 100
Q2. A 5-year-old girl with Wilms tumor receives dactinomycin as part of her treatment regimen. The nurse
monitoring this patient should recognize that dactinomycin is classified as which type of chemotherapeutic
agent?
A. Antitumor antibiotic that intercalates DNA and inhibits RNA synthesis
B. Topoisomerase inhibitor that prevents DNA strand religation
C. Antimetabolite that disrupts purine synthesis pathways
D. Mitotic inhibitor that prevents spindle fiber formation during cell division
Correct Answer: B
Rationale:
Dactinomycin (actinomycin D) is an antitumor antibiotic that intercalates into DNA and inhibits RNA synthesis.
Topoisomerase inhibitors prevent DNA strand religation, antimetabolites disrupt purine or pyrimidine synthesis, and mitotic
inhibitors affect spindle fibers, but dactinomycin specifically intercalates DNA to block transcription.
, SECTION 1 (cont.) | Chemotherapy Drug Classification & Mechanisms | APHON CHEMO CERTIFICATION EXAM 2026/2027 2026/2027
Q3 Question 3 of 100
Q3. A 10-year-old with osteosarcoma receives high-dose methotrexate therapy. The nurse administers
leucovorin rescue starting 24 hours after the methotrexate infusion. Leucovorin works by which mechanism to
prevent methotrexate toxicity?
A. Binding directly to methotrexate and enhancing its renal excretion
B. Providing a reduced folate that bypasses the blocked dihydrofolate reductase enzyme
C. Inhibiting thymidylate synthase to synergize with methotrexate effects
D. Alkalinizing the urine to prevent methotrexate crystal nephropathy
Correct Answer: C
Rationale:
Leucovorin (folinic acid) is a reduced folate that bypasses the dihydrofolate reductase enzyme blocked by methotrexate,
allowing DNA synthesis to resume in normal cells. It does not bind methotrexate, does not inhibit thymidylate synthase, and
while urine alkalinization is important, leucovorin's mechanism is metabolic rescue.
Q4 Question 4 of 100
Q4. A 4-year-old with neuroblastoma begins a chemotherapy regimen that includes cyclophosphamide. The
nurse understands that cyclophosphamide is classified as an alkylating agent and must be metabolized in the
liver to its active form. This activation process is called which term?
A. Prodrug activation requiring hepatic cytochrome P450 metabolism
B. Direct DNA intercalation without requiring metabolic conversion
C. Photodynamic activation through exposure to ultraviolet light
D. Enzymatic degradation by tumor-specific proteases in the microenvironment
Correct Answer: D
Rationale:
Cyclophosphamide is a prodrug that requires hepatic cytochrome P450 metabolism to form active metabolites
(4-hydroxycyclophosphamide and aldophosphamide) that exert the alkylating effect. It does not directly intercalate DNA,
does not require light activation, and is not activated by tumor-specific proteases.
, SECTION 1 (cont.) | Chemotherapy Drug Classification & Mechanisms | APHON CHEMO CERTIFICATION EXAM 2026/2027 2026/2027
Q5 Question 5 of 100
Q5. A 6-year-old with acute myeloid leukemia receives cytarabine as part of induction therapy. The nurse
recognizes that cytarabine is an antimetabolite analog of which naturally occurring nucleoside?
A. Deoxycytidine, which it mimics to inhibit DNA polymerase during S phase
B. Deoxyadenosine, which it replaces in the purine synthesis pathway
C. Thymidine, which it displaces during thymidylate synthesis
D. Deoxyguanosine, which it competes with during RNA transcription
Correct Answer: A
Rationale:
Cytarabine (Ara-C) is an analog of deoxycytidine that gets incorporated into DNA during S phase and inhibits DNA
polymerase, terminating chain elongation. It does not mimic adenosine, thymidine, or guanosine, but specifically competes
with deoxycytidine for incorporation into growing DNA strands.
Q6 Question 6 of 100
Q6. A 12-year-old with Hodgkin lymphoma receives doxorubicin as part of the ABVD regimen. The nurse
monitors for cardiotoxicity because doxorubicin's mechanism involves which process that affects cardiac cells?
A. Formation of iron-doxorubicin complexes that generate free radicals damaging cardiac myocytes
B. Direct viral reactivation in cardiac tissue causing myocarditis
C. Competitive blockade of calcium channels leading to arrhythmias
D. Immune-mediated destruction of cardiac myosin proteins
Correct Answer: B
Rationale:
Doxorubicin forms iron-drug complexes that generate reactive oxygen species (free radicals) causing oxidative damage to
cardiac myocytes, leading to dose-dependent cardiotoxicity. This is not viral reactivation, calcium channel blockade, or
immune-mediated, but rather direct oxidative injury from free radical generation.